Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ESCALON MEDICAL CORP | esmc_2018630-10k.htm |
| EX-32.1 - EXHIBIT 32.1 - ESCALON MEDICAL CORP | esmc_2018630-10kex321.htm |
| EX-31.2 - EXHIBIT 31.2 - ESCALON MEDICAL CORP | esmc_2017630-10kex312.htm |
| EX-31.1 - EXHIBIT 31.1 - ESCALON MEDICAL CORP | esmc_2018630-10kex311.htm |
| EX-23.2 - EXHIBIT 23.2 - ESCALON MEDICAL CORP | esmc_2018630-10kex232.htm |
| EX-23.1 - EXHIBIT 23.1 - ESCALON MEDICAL CORP | esmc_2018630-10kex231.htm |
Exhibit 32.2
Certification pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Escalon Medical Corp. (the “Company”) for the fiscal year ended June 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Wallace, Chief Operating Officer and Principal Financial & Accounting Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: September 28, 2018
/s/ Mark Wallace | |
Mark Wallace | |